Marble Spleen Disease Virus
Overview and Taxonomy of Marble Spleen Disease Virus
Marble Spleen Disease Virus (MSDV) occupies a distinctive, albeit often clinically overlooked, niche within the pantheon of avian viral pathogens. As the causative agent of marble spleen disease (MSD), this virus is primarily recognized as an acute, highly contagious infection of ring-necked pheasants (Phasianus colchicus), characterized by profound splenomegaly, respiratory distress, and sudden mortality. The significance of MSDV, however, extends beyond its immediate clinical impact in game birds. From a taxonomic and evolutionary perspective, MSDV serves as a critical model for understanding the divergence and pathogenic mechanisms of the Aviadenovirus genus, specifically within the complex and often conflated Group II avian adenoviruses [2, 5, 6]. The virus is not considered a zoonotic threat by organizations such as the WHO or CDC, but its economic impact on the upland game bird industry and its close antigenic relationship with other significant poultry pathogens make it a pathogen of considerable interest to the World Organisation for Animal Health (WOAH) and veterinary authorities globally.
Taxonomic Classification and Phylogenetic Position
MSDV is a non-enveloped, double-stranded DNA (dsDNA) virus belonging to the family Adenoviridae. Within this vast family, which infects a wide array of vertebrate hosts, avian adenoviruses are segregated into three distinct groups (I, II, and III) based on antigenic relatedness, genomic organization, and pathogenicity. MSDV is the archetypal and most well-characterized member of Group II of the avian adenoviruses [5, 6]. The other two members of this group, which are serologically indistinguishable from MSDV yet cause distinct clinical entities, are the hemorrhagic enteritis virus (HEV) of turkeys and the splenomegaly virus of chickens (also referred to as avian adenovirus type II) [2, 7].
For decades, the precise taxonomic relationship between these three viruses was a subject of intense debate. Early serological work, primarily using the agar gel immunodiffusion (AGID) test, demonstrated a complete cross-reactivity of splenic antigens from pheasants with MSDV and antiserum to turkey HEV. Furthermore, lines of identity formed between splenic antigens from naturally occurring MSD in pheasants, experimentally transmitted MSD in turkeys, and HEV of turkeys when tested against homologous sera [2, 8]. This immunological indistinguishability led initial classifications to consider them as the same virus, with host-specific disease manifestations. However, this view was radically altered by the advent of molecular virology. Definitive genotypic differentiation was achieved by Zhang and Nagaraja (1989) [7], who employed restriction endonuclease fingerprinting. By analyzing the DNA of the three serologically identical viruses with six different restriction enzymes (Bgl II, EcoRI, HindIII, Hha I, Xho I, and BamHI), they revealed markedly different DNA cleavage patterns. Five of the six enzymes produced unique and distinct fingerprints for each isolate, demonstrating unequivocal genetic differences that belied their serological similarity [7]. This seminal work established that while MSDV, HEV, and the splenomegaly virus of chickens are antigenically cross-reactive, they are genetically distinct entities, likely representing different virus species or distinct genotypes within a single species complex.
The most contemporary taxonomic understanding places MSDV within the genus Siadenovirus. This reclassification, supported by genomic sequencing and phylogenetic analysis, situates MSDV alongside other viruses that share a unique genome arrangement and a predicted sialidase gene, a hallmark of the Siadenovirus genus [4]. This is a significant departure from earlier classifications that placed it in the genus Aviadenovirus. The finding of a novel siadenovirus in a cockatiel (PsAdV-5) that is highly identical to budgerigar adenovirus 1 and phylogenetically related to MSDV and HEV underscores the broader diversity and evolutionary reach of this genus into psittacine species [4]. This suggests that the host range of these siadenoviruses may be wider than previously thought, and that MSDV-like viruses may be more prevalent in the avian population than currently documented.
Virion Morphology and Genomic Architecture
The physical structure of MSDV is consistent with the classic adenovirus architecture. As visualized by negative stain electron microscopy, the virion is an icosahedron approximately 90 nm in diameter [2]. The capsid is composed of 252 capsomeres, a characteristic feature of the Adenoviridae family [2]. The outer capsid is arranged with penton bases at each vertex from which fiber proteins project. These fibers are crucial for primary attachment to host cell receptors, dictating tissue tropism. As a non-enveloped virus, MSDV is remarkably resistant to lipid solvents like chloroform and fluorocarbon, a property that was historically exploited in early purification protocols to separate the infectious agent from cellular debris during Koch's postulate fulfillment [2].
The genome of MSDV is a linear dsDNA molecule. While a complete, fully annotated genome sequence for a pure MSDV isolate is not as publicly available as for some other adenoviruses, its size is inferred from its relatedness to HEV. The genetic differences revealed by restriction endonuclease analysis indicated a genome size typical of the Siadenovirus genus, likely in the range of 26-27 kilobase pairs [7]. The genomic architecture of siadenoviruses is distinct from that of aviadenoviruses or mastadenoviruses, particularly in the organization of the early transcription regions. A hallmark of the Siadenovirus genus is the presence of a predicted sialidase gene, which is unique among adenoviruses and is thought to play a role in viral egress or modulation of host immune responses, although its specific function in MSDV pathogenesis remains to be fully elucidated [4]. The genome encodes for approximately 30-35 proteins, including structural components (hexon, penton, fiber), enzymatic proteins (DNA polymerase, protease), and several non-structural regulatory proteins that subvert host cellular machinery to facilitate viral replication.
Host Range, Transmission, and Pathogenesis in Context
The natural host for MSDV is the ring-necked pheasant, but experimental infections have successfully demonstrated transmission to turkeys via oral, colonic, and intravenous routes [8]. While turkeys develop infection and characteristic intranuclear inclusions, the gross splenic lesions are more prominent and pathognomonic in pheasants [8]. The natural resistance to MSDV can also be influenced by host genetics. Selection experiments in White Leghorn chickens for high (HH) and low (LL) antibody responses to sheep red blood cells revealed a profound difference in susceptibility to MSDV. The LL line, bred for low antibody responsiveness, was demonstrably more resistant to MSDV infection, displaying significantly smaller relative spleen weights upon challenge compared to the HH line [1]. This finding indicates that resistance to MSDV is a heritable trait that can be inadvertently co-selected for during breeding for other immunological characteristics, highlighting a complex genetic interplay governing susceptibility to this virus. The F1 crosses were intermediate to the parental lines, suggesting an additive genetic basis for resistance without heterosis [1]. The presence of sex-linkage effects in the crosses further implies that genes on the sex chromosomes play a role in modulating the host response to MSDV [1].
Transmission occurs horizontally through the fecal-oral route, with the virus being shed in the droppings of infected birds. The exceptionally high environmental stability of the non-enveloped MSDV virion allows it to persist for extended periods in contaminated litter, soil, and on fomites, making biosecurity exceedingly difficult in free-range or open-pen pheasant operations. The incubation period is short, typically 4-6 days [9]. The virus exhibits a pronounced tropism for lymphoreticular tissues, particularly the spleen, but also the liver, bone marrow, bursa of Fabricius, and intestine-associated lymphoid tissue [8, 9]. The characteristic gross lesion is an enlarged, mottled spleen, often described as having a "marble-like" appearance due to alternating areas of white necrotic foci and red congested pulp [9]. Histopathologically, this corresponds to diffuse follicular necrosis, congestion, and the presence of pathognomonic large basophilic intranuclear inclusion bodies in splenic cells and macrophages [8, 9]. These inclusions, which are strongly positive for Group II avian adenovirus by immunohistochemistry, are the hallmark of active viral replication [9].
The virus-induced pathology in the spleen is a result of direct viral cytolysis combined with a robust, yet destructive, host immune response. The severe lymphoid depletion and necrosis can lead to profound immunosuppression, predisposing the bird to secondary bacterial infections. While MSDV is not a notifiable pathogen to the WOAH in the same category as Highly Pathogenic Avian Influenza (HPAI) or Newcastle Disease, its clinical presentation can be strikingly similar. Recent outbreaks of HPAI H5N1 in commercial pheasants in the United States were initially suspected to be marble spleen disease based on history and gross lesions, underscoring the critical need for laboratory-confirmed differential diagnosis via molecular assays (e.g., real-time RT-PCR) to distinguish MSDV from HPAI and other splenotropic viruses [3]. This diagnostic confusion highlights the importance of understanding MSDV epidemiology, especially as it remains a constant and often underdiagnosed background pathogen in pheasant populations worldwide.
Molecular Pathogenesis and Replication Mechanism of MSDV as an Avian Adenovirus
Marble Spleen Disease Virus (MSDV) is a non-enveloped, double-stranded DNA virus classified within the family Adenoviridae, genus Siadenovirus, and is a member of the avian adenovirus Group II [2, 5]. This classification is pivotal for understanding its molecular pathogenesis, as Group II adenoviruses are distinct from the more commonly studied Group I (aviadenoviruses) and Group III (atadenoviruses) in terms of genomic organization, tissue tropism, and disease manifestation [5, 6]. MSDV is serologically indistinguishable from, yet genetically distinct from, the hemorrhagic enteritis virus (HEV) of turkeys and the splenomegaly virus of chickens, forming a complex of closely related pathogens that cause lymphoproliferative and hemorrhagic diseases in galliform birds [7]. The virus is the etiological agent of marble spleen disease (MSD), an acute, highly contagious disease primarily of ring-necked pheasants (Phasianus colchicus), but also capable of infecting turkeys and chickens, where it induces splenomegaly and variable degrees of immunosuppression [1, 2, 8].
Virion Structure and Genomic Organization
The MSDV virion exhibits the classic adenovirus morphology: an icosahedral capsid approximately 75–90 nm in diameter, composed of 252 capsomeres arranged in a pseudo T=25 symmetry [2]. The capsid is non-enveloped, rendering the virus relatively resistant to environmental inactivation and lipid solvents such as chloroform [2]. The capsid is constructed from three major structural proteins: the hexon, which forms the bulk of the capsid and carries group- and type-specific antigenic determinants; the penton base, located at the vertices; and the fiber protein, which projects from the penton base and is responsible for primary attachment to host cell receptors [2]. The fiber protein is a critical determinant of cell tropism, and its structure in siadenoviruses, including MSDV, is distinct from that of mastadenoviruses, often being shorter and potentially interacting with different cell surface receptors, such as sialic acid residues or specific proteinaceous receptors on lymphoid cells.
The genome of MSDV is a linear, double-stranded DNA molecule, approximately 26–28 kilobase pairs in length, which is smaller than the genomes of Group I aviadenoviruses (typically 40–45 kbp) [7]. This reduced genome size is a hallmark of the Siadenovirus genus and reflects a more streamlined genetic repertoire, with fewer early transcription units dedicated to immune evasion and host cell manipulation. Restriction endonuclease fingerprinting has been instrumental in differentiating MSDV from HEV and the chicken splenomegaly virus, revealing markedly different DNA cleavage patterns with enzymes such as BglII, EcoRI, HindIII, HhaI, and XhoI, despite their serological cross-reactivity [7]. This genomic heterogeneity explains the differences in host range and pathogenicity observed among these viruses, with MSDV being particularly adapted to pheasants, while HEV is more pathogenic in turkeys [7, 8]. The genome is flanked by inverted terminal repeats (ITRs) that are essential for replication, and it encodes a DNA polymerase that is characteristic of adenoviruses, initiating replication via a protein-primed mechanism.
Viral Entry and Cellular Tropism
The molecular pathogenesis of MSDV begins with its entry into the host, typically via the oral or respiratory route [8]. The fiber protein mediates high-affinity attachment to specific receptors on the surface of target cells. While the precise receptor for MSDV has not been definitively identified, it is hypothesized to be a protein or carbohydrate moiety expressed on cells of the mononuclear phagocyte system and lymphocytes, given the virus’s pronounced tropism for lymphoid tissues. Following attachment, the penton base protein, containing an Arg-Gly-Asp (RGD) motif, interacts with cellular integrins (e.g., αvβ3 or αvβ5), triggering clathrin-mediated endocytosis. The acidic environment of the endosome facilitates a conformational change in the capsid, leading to endosomal escape and release of the partially uncoated virion into the cytoplasm. The viral particle then traffics to the nuclear pore complex, where the viral DNA is imported into the nucleus, initiating the replication cycle.
MSDV exhibits a profound and selective tropism for cells of the spleen, bone marrow, liver, lung, bursa of Fabricius, and intestine-associated lymphoid tissue (IALT) [8]. The spleen is the primary target organ, where the virus infects cells within the splenic lymphoreticular network, specifically macrophages, dendritic cells, and B lymphocytes [2, 8]. This tropism is not merely a passive event but is driven by the expression of specific host factors and the virus’s ability to subvert the host’s innate immune defenses within these tissues. The infection of these cells triggers a cascade of events leading to the characteristic gross pathology: splenomegaly, often three times the normal size, with a mottled, “marble-like” appearance due to alternating areas of lymphoid hyperplasia, necrosis, and hemorrhage [9].
Replication Cycle and Host Cell Manipulation
Once the viral DNA is delivered to the nucleus, the replication cycle proceeds in a temporally regulated cascade of early (E) and late (L) gene expression. The early genes are transcribed by host RNA polymerase II and encode non-structural proteins responsible for transactivating viral gene expression, modulating the host cell cycle, and evading the host immune response. The E1A-like region of MSDV, though less characterized than in mastadenoviruses, is thought to drive the cell into S-phase, creating a favorable environment for viral DNA replication. This is particularly significant in the context of the spleen, where the virus induces a state of lymphoproliferation, leading to the expansion of infected and bystander cells [9].
The E3 region of adenoviruses is typically a hotbed for immune evasion genes. In MSDV, the E3 region likely encodes proteins that inhibit apoptosis and downregulate major histocompatibility complex (MHC) class I molecules on the surface of infected cells, preventing recognition and killing by cytotoxic T lymphocytes (CTLs). This is a critical mechanism for establishing a persistent infection within the lymphoid organs. The virus also encodes a viral DNA polymerase that replicates the genome via a protein-primed mechanism, producing concatemeric intermediates that are subsequently cleaved into unit-length genomes and packaged into progeny virions.
Late gene expression, driven by the major late promoter, produces the structural proteins (hexon, penton base, fiber, core proteins) required for capsid assembly. Assembly occurs in the nucleus, where viral particles form paracrystalline arrays that are visible by light microscopy as large, basophilic or eosinophilic intranuclear inclusion bodies [2, 8, 9]. These inclusions are a pathognomonic feature of MSDV infection and are found in splenic cells, as well as in hepatocytes, renal tubular epithelium, and cells of the bone marrow and bursa [8, 9]. The mature progeny virions are released upon cell lysis, which is mediated by the virus-encoded adenovirus death protein (ADP), leading to the necrotic foci observed in the spleen and other organs.
Molecular Pathogenesis: The Splenic Microenvironment and Immunopathology
The hallmark of MSDV pathogenesis is the profound disruption of the splenic architecture and function. The virus does not simply replicate and destroy cells; it actively manipulates the host immune response, leading to a complex immunopathological syndrome. The initial infection of splenic macrophages and dendritic cells triggers a robust but dysregulated inflammatory response. Transcriptomic and proteomic studies of related viral infections in the spleen, such as those caused by Newcastle disease virus (NDV) and Marek’s disease virus (MDV), provide a framework for understanding the molecular events likely occurring in MSDV infection [10-13, 15, 19]. These studies have shown that viral infection of the spleen leads to the differential expression of thousands of genes, including those involved in interferon signaling, the eIF2 translation initiation pathway, and the extracellular matrix (ECM) [10-12, 21].
In MSDV infection, the early phase is characterized by hyperplasia of the lymphoreticular cells, driven by viral oncogenes and the release of growth factors from infected macrophages [2]. This is followed by a phase of severe lymphoid depletion and necrosis, particularly in the follicular areas of the spleen [9]. The necrosis is not solely due to direct viral cytolysis but is also a consequence of the host’s immune response. The upregulation of pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α, by infected macrophages and T cells creates a “cytokine storm” that contributes to tissue damage [13]. Furthermore, the virus may induce the expression of matrix metalloproteinases (MMPs), particularly MMP-13 and MMP-14, which degrade the extracellular matrix, leading to the breakdown of the splenic architecture and facilitating the spread of the virus [12]. This ECM degradation is a critical pathology event, contributing to the loss of tissue integrity and the hemorrhagic tendencies observed in severe cases.
A key aspect of MSDV pathogenesis is its ability to induce immunosuppression, making the host susceptible to secondary bacterial and viral infections. The virus targets and destroys B lymphocytes in the spleen and bursa of Fabricius, impairing humoral immunity [8, 16]. This is analogous to the immunosuppression caused by infectious bursal disease virus (IBDV), which also targets B cells and leads to vaccine failures [16, 22]. The downregulation of MHC class II pathway genes, as observed in MDV infection, may also be a strategy employed by MSDV to impair antigen presentation and T-cell help, further crippling the adaptive immune response [18]. The presence of suppressor macrophages, which inhibit mitogen-induced proliferation of T cells, has been documented in other avian viral infections and likely plays a role in MSDV-induced immunosuppression [17].
Genetic Determinants of Pathogenicity and Host Resistance
The severity of MSDV infection is modulated by both viral genetics and host genetics. Restriction enzyme analysis has clearly demonstrated that MSDV is a distinct genetic entity from HEV, despite their serological cross-reactivity [7]. These genetic differences likely map to specific virulence genes, such as those encoding the fiber protein (determining cell tropism), the E3 region (immune evasion), and the DNA polymerase (replication efficiency). The M, F, and HN genes (or their functional analogs in adenoviruses) are critical determinants of pathogenicity in lymphoid organs, as demonstrated in NDV, where the replacement of these genes from a less virulent strain with those from a more virulent strain conferred the ability to cause severe splenic necrosis [14]. By analogy, the specific alleles of the MSDV hexon, fiber, and E3 genes are likely responsible for its unique pathogenicity in pheasants.
Host genetic resistance also plays a significant role. Studies in chickens selected for high (HH) or low (LL) antibody response to sheep red blood cells have shown that the LL line is significantly more resistant to MSDV-induced splenomegaly than the HH line [1]. This suggests that the genetic pathways governing general immune responsiveness also influence susceptibility to MSDV. The F1 crosses were intermediate, indicating a polygenic mode of inheritance with evidence of sex-linkage and negative heterosis [1]. This implies that resistance is not simply a matter of a strong antibody response but involves a complex interplay of innate and adaptive immune mechanisms. The differential expression of genes in the eIF2 family, which controls the host cell’s protein synthesis machinery, has been linked to resistance to NDV and may be relevant to MSDV [21]. Resistant birds may be better able to shut off viral protein synthesis through the phosphorylation of eIF2α, limiting viral replication. Furthermore, the expression of interferon-stimulated genes (ISGs) like IFIT5, which is highly expressed in the spleen and acts as an enhancer of innate immunity, is likely a critical determinant of the early control of MSDV infection [20, 21].
In conclusion, the molecular pathogenesis of MSDV is a multifaceted process involving a precise interplay between viral replication machinery, host cell manipulation, and immunopathological damage. The virus’s tropism for the spleen, its ability to induce lymphoproliferation followed by necrosis, and its capacity to subvert the host immune response are the key drivers of disease. The genetic distinctions between MSDV and other Group II adenoviruses, coupled with host genetic variability, determine the ultimate outcome of infection, ranging from subclinical splenomegaly to fatal disease. Understanding these molecular mechanisms is essential for the development of effective vaccines and control strategies, particularly given the economic importance of pheasant and turkey farming and the potential for MSDV to cause significant morbidity and mortality in these species.
Clinical Signs and Pathological Features of Marble Spleen Disease
Marble Spleen Disease (MSD), a highly contagious lymphoproliferative and immunosuppressive condition of pheasants (primarily Phasianus colchicus), is etiologically linked to a Group II avian adenovirus, formally classified as the Marble Spleen Disease Virus (MSDV) [2, 5, 7]. The disease is a significant cause of morbidity and mortality in the commercial game bird industry, often manifesting as acute death in otherwise healthy-appearing flocks. The clinical trajectory and pathological lesions are hallmarks of the disease, reflecting the virus’s profound tropism for lymphoid tissues, particularly the spleen, and its ability to induce a rapid, necrotizing lymphoproliferative response [5, 9]. A deep understanding of these features is critical for field diagnosis, differential diagnosis from other causes of acute splenic pathology such as Highly Pathogenic Avian Influenza (HPAI) [3], and for implementing effective control measures.
Clinical Presentation
The clinical course of MSDV infection is frequently peracute to acute, especially in naive populations. The incubation period in experimental settings, following oral, colonic, or intravenous administration of virulent splenic extracts, is typically 4 to 6 days [1, 8]. In natural outbreaks, mortality can spike rapidly, often being the first and only sign recognized by producers. Affected birds, commonly young pheasants between 4 to 8 weeks of age, may exhibit a short period of depression, inappetence, and ruffled feathers before succumbing [9]. Dyspnea or open-mouth breathing may be noted in some birds, correlating with pulmonary congestion and edema observed at necropsy [9]. A significant diagnostic challenge is that many birds are found dead without any observed premonitory signs, a feature that can lead to initial misdiagnosis.
Genetic factors can influence the clinical response to MSDV challenge. In experimental models using lines of White Leghorns selected for differential antibody responses, a clear difference in resistance was observed. The high-antibody line (HH) demonstrated heavier relative spleen weights post-infection compared to the low-antibody line (LL), suggesting a greater pathological response and lower resistance. Conversely, the LL line exhibited greater resilience, with F1 crosses showing intermediate susceptibility, indicating a sex-linked component to resistance without evidence of heterosis [1]. This suggests that host genetic background modulates the severity of splenomegaly and, by extension, clinical outcomes. It is critical to note that while MSDV is a Group II avian adenovirus, it is serologically indistinguishable from hemorrhagic enteritis virus of turkeys (HEV) and the splenomegaly virus of chickens [7]; thus, clinical signs in turkeys may lean more towards intestinal hemorrhage, whereas in pheasants, the splenic pathology is the dominant clinical feature.
Gross Pathological Features
The pathognomonic gross lesion of MSDV infection is profound splenomegaly. In naturally occurring cases, the spleen is routinely described as enlarged to approximately two to three times its normal size, often bulging on cut section, and having a distinctive "marbled" or mottled appearance [9]. This marbled pattern, which gives the disease its name, arises from a heterogeneous parenchyma composed of alternating foci of white to tan necrotic or lymphoproliferative foci interspersed with dark red, congested, or hemorrhagic areas [9]. The splenic capsule is typically tense and may be friable.
Beyond the spleen, other pathological changes are less consistent but can be informative. The lungs are frequently congested and edematous, correlating with the dyspneic signs observed clinically. Hepatic enlargement and congestion are occasionally reported, although the liver is not the primary target organ in MSDV as it is in some other adenoviral conditions like Inclusion Body Hepatitis (IBH) [5, 6]. The bursa of Fabricius may show atrophy, reflecting the virus’s tropism for lymphoid tissues and its immunosuppressive capacity. A critical differential diagnosis in the field is HPAI, which can present with identical gross lesions of splenomegaly, pulmonary congestion, and sudden death. As highlighted in recent outbreak investigations, HPAI H5N1 (clade 2.3.4.4b) in ring-necked pheasants initially raised suspicion for MSD based on gross pathology alone, underscoring the absolute necessity of molecular confirmation (e.g., RT-PCR) for a definitive diagnosis [3]. The absence of significant hemorrhage in the intestinal tract, which is characteristic of HEV in turkeys, helps differentiate MSD in pheasants.
Histopathological Features and Cellular Pathogenesis
The microscopic pathology of MSDV is defined by a severe, diffuse lymphoproliferative and necrotizing splenitis. The most salient diagnostic lesion is the presence of large, basophilic to amphophilic intranuclear inclusion bodies within splenic cells. These inclusions, which are considered pathognomonic for Group II avian adenovirus infection, are strongly positive for viral antigen by immunohistochemistry [9]. Ultrastructurally, these inclusions correspond to paracrystalline arrays of non-enveloped icosahedral adenovirus particles approximately 75–80 nm in diameter [2].
The microscopic architecture of the spleen is markedly disrupted. Early in the infection, there is pronounced hyperplasia of the lymphoreticular cells [2]. This is rapidly followed by diffuse, severe follicular necrosis [9]. The white pulp becomes effaced by sheets of proliferating histiocytic and lymphoblastoid cells interspersed with areas of coagulative necrosis, karyorrhectic debris, and fibrin deposition. The red pulp is congested with erythrocytes and infiltrated by heterophils and macrophages. The intranuclear inclusions are most abundant within the cells of the lymphoreticulum, large, transformed cells, and are often surrounded by a clear halo [2, 9].
The tissue tropism of MSDV, similar to other Group II adenoviruses, extends beyond the spleen to other lymphoid aggregations. Intranuclear inclusions have been consistently identified in the liver (Kupffer cells and hepatocytes), lung, bone marrow, bursa of Fabricius, and intestine-associated lymphoid tissue (IALT) [8]. This systemic dissemination explains the profound immunosuppression associated with MSD, as the virus depletes critical immune effector cells across multiple organs. The destruction of the bursal lymphoid follicles and the splenic parenchyma predisposes surviving birds to secondary bacterial and viral infections. The inflammatory response is characterized by a relative lack of a robust lymphocytic infiltrate against the virally infected cells, a trait that may be attributed to viral immune evasion strategies, including the downregulation of antigen presentation pathways, analogous to mechanisms observed in other DNA viruses like Marek’s disease virus where MHC-II pathway genes are suppressed [18].
In summary, the clinical signs of MSD are dominated by acute mortality with minimal premonitory illness. The cardinal pathological triad of marked splenomegaly, a marbled splenic parenchyma, and the microscopic identification of basophilic intranuclear inclusion bodies within splenic lymphoreticular cells is diagnostic. The disease represents a classic viral lymphoproliferative and immunosuppressive condition, with the severity of the splenic lesions being a direct reflection of viral virulence and host susceptibility. Given the potential for gross overlap with HPAI and the critical economic implications for the game bird industry, definitive diagnosis through virological and molecular methods (e.g., AGPT, PCR, and sequencing) is mandatory [2, 3, 7]. The differential regulation of immune responses, such as the expression of eIF2 family genes observed in other avian viral diseases [21], may also play a role in the susceptibility of pheasants to the fulminant pathology of MSDV.
Epidemiology: Host Range, Transmission, and Geographic Distribution
Marble Spleen Disease Virus (MSDV) occupies a distinct ecological niche within the family Adenoviridae, genus Siadenovirus, and is formally classified as a Group II avian adenovirus alongside the antigenically related hemorrhagic enteritis virus (HEV) of turkeys and the splenomegaly virus of chickens [2, 5, 7]. Understanding the epidemiological parameters of MSDV, its host range, modes of transmission, and geographic distribution, is of paramount importance for the poultry and game bird industries, as this pathogen imposes significant economic burdens through mortality, condemnation at slaughter, and immunosuppression that predisposes flocks to secondary infections. The epidemiological landscape of MSDV, however, remains less comprehensively characterized than that of other avian adenoviruses, owing in part to historical challenges in viral isolation and the propensity for subclinical infections to obscure true prevalence. This section synthesizes the available literature to provide an exhaustive analysis of the virus’s circulation dynamics, drawing upon experimental transmission studies, field outbreak investigations, and comparative virology.
Host Range: Primary and Susceptible Species
The primary natural host of MSDV is the ring-necked pheasant (Phasianus colchicus), in which the virus produces the characteristic syndrome of splenic enlargement, mottling, and parenchymal necrosis that gives the disease its name [8, 9]. Experimental infections have unequivocally demonstrated that turkeys (Meleagris gallopavo) are also susceptible, developing intranuclear inclusion bodies in splenic cells and other lymphoid tissues following oral, colonic, or intravenous inoculation with cell-free splenic extracts from naturally infected pheasants [8]. Importantly, while turkeys support viral replication and develop microscopic lesions, the gross splenic pathology is markedly less pronounced in this species compared to pheasants, suggesting species-specific differences in the amplitude of the host inflammatory response [8]. This differential pathology has implications for surveillance: turkeys may serve as subclinical reservoirs that perpetuate viral circulation within multi-species production systems.
A critical observation bridging avian adenovirology is the serological cross-reactivity between MSDV, HEV of turkeys, and the chicken splenomegaly virus. Agar gel immunodiffusion tests reveal lines of identity between splenic antigens derived from naturally occurring MSD in pheasants, experimentally transmitted MSD in turkeys, and HEV in turkeys when reacted with homologous antisera [8]. This antigenic relatedness has historically complicated definitive diagnosis, as the three viruses are serologically indistinguishable despite being genetically distinct [7]. Restriction endonuclease fingerprinting using enzymes such as EcoRI, HindIII, and HhaI reveals markedly different DNA cleavage patterns among these isolates, confirming that they are separate viral entities that share a common group antigen [7]. From an epidemiological standpoint, this means that serosurveys using group-specific reagents cannot differentiate which specific siadenovirus has circulated in a population, necessitating molecular approaches for precise host range determinations.
The breadth of MSDV’s host range beyond galliform birds remains incompletely explored. However, insights from related siadenoviruses suggest the potential for broader permissiveness. A novel siadenovirus, psittacid adenovirus 5 (PsAdV-5), was identified in a cockatiel (Nymphicus hollandicus) with chronic liver disease, and phylogenetic analysis placed this virus in a clade closely related to MSDV and HEV [4]. This finding raises the possibility that psittacine birds, and by extension, other avian orders, could be susceptible to MSDV infection or carry related siadenoviruses that complicate diagnostic interpretation. The detection of siadenoviruses in seven psittacine species, including budgerigars, umbrella cockatoos, and eastern rosellas, underscores the genus’s adaptability across taxonomic boundaries [4]. Whether MSDV itself can productively infect such species remains an open question, but the epidemiological principle of host-range plasticity among adenoviruses cautions against assuming strict host restriction.
In chickens, the epidemiological picture is particularly nuanced. While MSDV does not typically cause overt disease in domestic fowl, experimental studies have shown that layer-type chickens exhibit differential susceptibility to MSDV based on genetic background [1]. White Leghorn lines selected for high (HH) or low (LL) antibody response to sheep red blood cells displayed markedly different responses to MSDV inoculation at 50 days of age. Relative spleen weights in control (uninoculated) chicks were heavier in the HH line compared to the LL line, and following MSDV challenge, LL chicks demonstrated significantly greater resistance, with F1 crosses exhibiting intermediate phenotypes [1]. Evidence of sex linkage and negative heterosis suggests that host genetic factors are major determinants of susceptibility, with implications for genetic selection strategies in poultry breeding. The observation that MSDV can replicate and induce splenomegaly in chickens, albeit with variable outcomes depending on host genetics, indicates that chickens may serve as silent vectors or reservoirs, particularly in mixed-species rearing environments.
Experimental data also reveal that the route of infection influences host range dynamics. Oral inoculation, the most likely natural route, successfully transmits MSDV to both pheasants and turkeys, as does colonic and intravenous administration [8]. This suggests that fecal-oral transmission is the primary mechanism of inter-host spread, and that environmental contamination with infected feces can maintain viral circulation even in the absence of direct bird-to-bird contact. The permissiveness of turkey embryo chorioallantoic membrane and yolk sac, as well as turkey embryo fibroblast and turkey kidney cell cultures, however, was negative in early attempts at in vitro propagation, indicating strict cellular tropism requirements that are not fully recapitulated in conventional culture systems [8]. This limitation has historically hindered systematic host range studies, as many potential host species cannot be tested without access to live animal experimentation.
Transmission Dynamics: Routes, Reservoirs, and Shedding Patterns
Understanding the transmission ecology of MSDV is foundational to implementing effective biosecurity measures. The virus is shed in high concentrations from the spleens of infected birds, and the demonstration that cell-free supernatant fluids of splenic suspensions can transmit disease via the oral route underscores the importance of horizontal transmission through contaminated feed, water, and litter [8]. Vertical transmission, while documented for other avian adenoviruses such as those causing egg drop syndrome (Group III), has not been conclusively demonstrated for MSDV. However, the general capacity of adenoviruses for transovarial transmission, as highlighted in comprehensive reviews of fowl adenovirus epidemiology, warrants caution; the potential for MSDV to be egg-transmitted cannot be excluded and represents a critical knowledge gap [5].
The persistence of MSDV in the environment is a key epidemiological parameter. Adenoviruses are non-enveloped, double-stranded DNA viruses that exhibit remarkable stability outside the host, resisting desiccation, moderate temperatures, and many common disinfectants [5]. For MSDV specifically, the ability to remain infectious in litter and soil for extended periods facilitates indirect transmission between successive flocks, particularly in multi-age production systems where all-in/all-out management is not practiced. The presence of intranuclear inclusion bodies in cells of the spleen, bone marrow, liver, lung, bursa of Fabricius, and intestine-associated lymphoid tissue (IALT) in experimentally infected birds indicates that the virus disseminates systemically and can be shed through multiple routes, including respiratory secretions and feces [8]. The involvement of the IALT is especially significant, as it provides a direct conduit for viral shedding into the intestinal lumen, thereby amplifying environmental contamination.
A particularly compelling aspect of MSDV transmission was highlighted during the 2022–2023 highly pathogenic avian influenza (HPAI) H5N1 outbreak in the United States. In December 2023, an outbreak on a commercial ring-necked pheasant farm in Pennsylvania initially presented clinical signs and gross lesions highly suggestive of marble spleen disease, splenomegaly, depression, and elevated mortality. Molecular testing, however, confirmed HPAI H5N1 clade 2.3.4.4b, genotype C2.1 [3]. Predictive mathematical modeling estimated that the time from viral introduction onto the farm to confirmed detection was 15 days (95% CI, 11–23 days), a period similar to or longer than that described for domestic poultry [3]. This case illustrates two critical epidemiological points: first, MSDV and HPAI can be clinically indistinguishable, necessitating laboratory confirmation; second, the prolonged pre-detection period implies that MSDV surveillance programs must account for the possibility of co-circulating pathogens that may mask the true incidence of MSDV. The study also noted that bioexclusion measures were insufficient to prevent initial exposure due to industry rearing practices, pheasants are often housed in outdoor pens or partially enclosed facilities that permit contact with wild birds, but biocontainment procedures effectively curtailed within-farm spread [3]. This suggests that MSDV transmission within farms may follow similar dynamics: environmental introduction from wild reservoirs is difficult to prevent, but once present, strict sanitation and bird movement controls can limit amplification.
Seasonal patterns of transmission are poorly documented for MSDV specifically, but comparative data from other avian adenoviruses and from retroviral infections in wild turkeys provide a framework for hypothesis generation. In wild turkeys, lymphoproliferative disease virus (LPDV) prevalence peaks in winter, a pattern attributed to increased physiological stress, crowding at feeding sites, and prolonged environmental stability of the virus at lower temperatures [23]. It is biologically plausible that MSDV exhibits a similar winter peak, although formal longitudinal studies in pheasant populations are lacking. The role of wild birds as maintenance hosts is suggested by the detection of MSD-like lesions in free-ranging pheasants in Korea, where two birds maintained in an outdoor closed pen died within days of each other, with spleens enlarged threefold and intranuclear basophilic inclusion bodies confirmed by immunohistochemistry [9]. The outdoor housing and proximity to wild bird populations imply that spillover from sylvatic cycles is a recurring risk.
Mechanical transmission by fomites, personnel, and equipment is another established route for avian adenoviruses [5]. The high viral load in splenic tissue makes contaminated slaughter equipment, transport crates, and processing plant environments potent sources of spread. In the context of integrated poultry operations where pheasants, turkeys, and chickens may be raised in proximity, the potential for inter-species transmission is elevated. The genetic distinctness of MSDV from HEV, despite serological identity, complicates molecular epidemiological tracing; restriction endonuclease typing provides a tool for distinguishing these viruses and tracing outbreak strains, but this approach is not routinely employed in diagnostic laboratories [7].
Geographic Distribution: Global Patterns and Underdetection
The geographic distribution of MSDV is likely global in scope, mirroring the distribution of its primary host, the ring-necked pheasant, which has been introduced for hunting and farming on every continent except Antarctica. Confirmed reports of MSDV originate from North America, Europe, and Asia. The earliest definitive isolations and fulfillment of Koch’s postulates were conducted in the United States in the mid-1970s, where the virus was purified from naturally infected pheasants and successfully transmitted to turkeys, with reisolation confirming causality [2]. Subsequent field reports from Korea in 2001 described an outbreak in outdoor penned pheasants, with histopathological findings of diffuse severe follicular necrosis and intranuclear basophilic inclusion bodies that were strongly immunopositive for Group II avian adenovirus [9].
The paucity of reports from many regions likely reflects diagnostic underdetection rather than true absence. As comprehensive reviews of fowl adenovirus infections note, diagnosis of Group II adenovirus infections cannot rely on clinical signs alone, as the gross and microscopic lesions, while suggestive, are not pathognomonic [5]. The availability of molecular diagnostic techniques, including real-time PCR and restriction endonuclease fingerprinting, is limited in many parts of the world, especially in developing countries where pheasant farming is less industrialized. Furthermore, the propensity for subclinical infections, particularly in turkeys and chickens, means that MSDV can circulate undetected in a region for years before an index case is recognized. The phenomenon of misdiagnosis as other pathogens, such as HPAI or Newcastle disease, further obscures the true distribution [3].
From a regulatory and economic perspective, MSDV is not listed by the World Organisation for Animal Health (WOAH) as a notifiable disease, and there is no systematic global surveillance program. This contrasts with diseases such as Newcastle disease and avian influenza, which are subject to mandatory reporting under WOAH guidelines. The absence of international reporting requirements means that the geographic distribution of MSDV is inferred from peer-reviewed case reports and industry surveys, which are inherently biased toward regions with active veterinary research programs. It is highly probable that MSDV is enzootic in pheasant populations across Europe, where hunting preserves are common, and in Asia, where pheasant farming for meat and feathers is economically significant. In China, the presence of novel variant infectious bursal disease virus (IBDV) strains that damage the bursa and spleen has overshadowed MSDV surveillance, but the co-circulation of multiple immunosuppressive viruses in the same production systems suggests that MSDV may be more prevalent than recognized [16, 24].
The potential for geographic expansion exists through the international trade of live birds, hatching eggs, and game bird carcasses. While the role of ornamental and pet birds in spreading siadenoviruses is increasingly documented, with novel siadenoviruses identified in cockatiels, parakeets, and other psittacines, the extent to which the legal and illegal trade in these species contributes to MSDV dissemination is unknown [4]. The global movement of poultry and game birds for breeding and restocking purposes creates pathways for viral introduction into naive populations, and the absence of routine quarantine screening for MSDV in most countries represents a significant vulnerability.
In summary, the epidemiology of MSDV is characterized by a primary host range centered on galliform birds, pheasants and turkeys, with secondary susceptibility in chickens that is modulated by host genetics. Transmission occurs predominantly via the fecal-oral route, with environmental persistence enabling indirect spread, and the potential for vertical transmission remains an unresolved question. Geographically, MSDV is likely present wherever pheasants are farmed, but formal documentation is concentrated in North America and East Asia, with substantial gaps in Europe, Africa, and South America. The frequent co-occurrence of MSDV with other pathogens, the difficulty of clinical diagnosis, and the absence of international surveillance programs collectively ensure that the true epidemiological footprint of this virus is substantially larger than the published record suggests. Future work must prioritize prospective prevalence studies using molecular diagnostics, experimental elucidation of the vertical transmission risk, and risk-factor analyses to identify management practices that precipitate clinical outbreaks.
Diagnostic Approaches: Serological, Histological, and Molecular Detection
The accurate and definitive diagnosis of Marble Spleen Disease Virus (MSDV) is a multifaceted endeavor, requiring a strategic integration of serological, histological, and molecular techniques. Given that MSDV is a Group II avian adenovirus (Siadenovirus) that induces a pathognomonic splenomegaly in pheasants and shares antigenic and genetic kinship with other members of this group, notably Hemorrhagic Enteritis Virus (HEV) of turkeys and the Splenomegaly Virus of chickens, diagnostic approaches must be sufficiently robust to differentiate it from these closely related pathogens as well as from other viral agents that cause similar gross pathology, such as velogenic Newcastle disease virus (NDV) and highly pathogenic avian influenza (HPAI) [3, 5, 7]. The diagnostic pipeline typically progresses from initial clinical suspicion and gross pathology through histopathological confirmation, serological screening, and culminates in definitive molecular characterization.
Histological Detection: The Cornerstone of Morphological Diagnosis
Histopathological examination remains an indispensable, first-line diagnostic tool for MSDV, providing rapid, cost-effective, and highly suggestive evidence of infection. The hallmark lesion, observable under light microscopy, is the presence of characteristic intranuclear inclusion bodies within splenic cells [2, 8, 9]. These inclusions are typically basophilic, amphophilic, or eosinophilic, and they represent the viral replication factories (viral factories) within the host cell nucleus. Their presence is considered a definitive criterion for infection in both naturally occurring and experimentally transmitted cases [8]. The cellular targets of MSDV are predominantly the lymphoreticular cells of the spleen, where the virus induces a pronounced hyperplasia of the lymphoreticulum, leading to the grossly observable splenomegaly [2].
The histopathological landscape of an MSDV-infected spleen is not limited to inclusion bodies. Diffuse, severe follicular necrosis is a consistent finding, often accompanied by congestion and edema in the surrounding parenchyma [9]. The spleen’s architecture becomes disrupted as the white pulp undergoes necrotic changes, while the red pulp may show marked hyperemia. In advanced cases, the mottled appearance of the spleen, the “marble” effect, is a macroscopic correlate of this underlying microscopic chaos, where areas of necrosis (pale foci) are juxtaposed against areas of congestion and hemorrhage (dark red foci). Immunohistochemistry (IHC) can be employed to enhance the specificity of histological diagnosis. Using antibodies directed against Group II avian adenoviruses, IHC can confirm that the observed intranuclear inclusions are indeed viral in origin, as demonstrated by the strong positive staining of these inclusions in pheasants diagnosed with MSDV in Korea [9]. This technique is particularly valuable when inclusions are sparse or atypical, or when differentiating MSDV from other viral infections that can cause splenic pathology, such as infectious bursal disease virus (IBDV) or reticuloendotheliosis virus (REV), which also induce lymphoid depletion and necrosis in the spleen [13, 16, 27]. The utility of histopathology extends to monitoring the severity of disease, as lesion scoring systems, similar to those developed for IBDV in the bursa and spleen, can be adapted to quantify the degree of follicular necrosis and inclusion body formation, providing a semi-quantitative measure of pathological progression [22].
Serological Approaches: Detecting the Humoral Response
Serological assays are critical for population-level surveillance, retrospective diagnosis, and epidemiological studies, particularly in identifying subclinical infections or determining the immune status of a flock. The Agar Gel Precipitin Test (AGPT) has historically been the cornerstone of serological diagnosis for MSDV. This assay detects antibodies against soluble viral antigens, typically derived from splenic extracts of infected birds. The AGPT has been instrumental in establishing the antigenic relationship between MSDV and other Group II adenoviruses. Early foundational work demonstrated that MSDV antigen forms lines of identity (fusion) with HEV antigen when reacted against homologous antisera, confirming their close serological relationship [2, 8]. This cross-reactivity, however, presents a significant diagnostic limitation: the AGPT cannot reliably distinguish between MSDV, HEV, and the chicken splenomegaly virus, as they are serologically indistinguishable by this method [7].
Despite this limitation, the AGPT remains a valuable tool for screening flocks for exposure to Group II adenoviruses. The test is simple, inexpensive, and does not require sophisticated equipment, making it suitable for field-based diagnostics. The antigen is typically prepared by homogenizing spleens from infected birds, followed by clarification and concentration steps, such as chloroform or fluorocarbon extraction and ultracentrifugation on a cesium chloride cushion, to purify the viral antigen [2]. More modern serological techniques, such as Enzyme-Linked Immunosorbent Assay (ELISA), offer higher throughput and quantitative data, but their development for MSDV has been hampered by the same antigenic cross-reactivity issues. The development of a specific, MSDV-exclusive serological test would require the identification and use of unique, non-cross-reactive epitopes, which, given the genetic differences revealed by restriction endonuclease analysis, may be possible but has not been widely commercialized [7]. For the practicing diagnostician, a positive AGPT result indicates exposure to a Group II avian adenovirus, but definitive speciation requires molecular confirmation.
Molecular Detection: The Gold Standard for Definitive Identification and Differentiation
Molecular diagnostic techniques have revolutionized the detection and differentiation of MSDV, overcoming the specificity limitations of serology and the sensitivity constraints of histology. The genetic material of MSDV, a double-stranded DNA genome, is amenable to a variety of nucleic acid-based detection methods.
Restriction Endonuclease Fingerprinting (RFLP) was one of the first molecular tools applied to differentiate the serologically indistinguishable members of the avian adenovirus type-II group. By digesting the viral DNA with specific restriction enzymes (e.g., Bgl II, EcoRI, HindIII, Hha I, Xho I), researchers demonstrated markedly different DNA cleavage patterns between MSDV, HEV, and chicken splenomegaly virus, providing unequivocal evidence of their genetic divergence [7]. This technique, while powerful, is labor-intensive and requires relatively large quantities of purified viral DNA.
The advent of Polymerase Chain Reaction (PCR) and its real-time variant (qPCR or RRT-PCR) has provided the diagnostic community with rapid, highly sensitive, and specific tools. PCR assays can be designed to target conserved regions of the adenovirus genome (e.g., the hexon gene) for broad detection of Group II viruses, or they can be tailored to amplify unique sequences specific to MSDV. The use of PCR is now standard practice for confirming MSDV infection, especially in cases where histopathology is equivocal or when co-infections are suspected. For instance, during the 2022 HPAI outbreak in ring-necked pheasants in the United States, clinical signs and gross lesions were initially suggestive of MSDV, but RRT-PCR for avian influenza virus (AIV) quickly identified the true etiological agent, HPAI H5N1, highlighting the critical need for molecular diagnostics to rule out other high-consequence pathogens [3]. Similarly, PCR is essential for differentiating MSDV from other splenotropic viruses like NDV and IBDV, which can cause similar lymphoid depletion and necrosis [13, 25].
Next-Generation Sequencing (NGS) and whole-genome sequencing (WGS) represent the current frontier in MSDV diagnostics. These techniques provide the ultimate resolution for pathogen characterization, enabling not only definitive identification but also detailed phylogenetic and phylodynamic analyses. NGS can be performed directly on tissue samples, bypassing the need for virus isolation, which has historically been difficult for MSDV [8]. This is particularly advantageous for detecting novel or divergent strains. The application of NGS was instrumental in identifying a novel siadenovirus in a cockatiel with chronic liver disease, a virus that was highly identical to budgerigar adenovirus 1 but distinct from other psittacine adenoviruses, demonstrating the power of this technology to uncover viral diversity [4]. For MSDV, WGS can provide high-resolution data to track the origin and spread of outbreaks, identify markers of virulence, and inform vaccine development. Tiled-PCR approaches, which have been successfully applied to other large DNA viruses like Infectious Spleen and Kidney Necrosis Virus (ISKNV) in aquaculture, could be adapted for MSDV to enable rapid, field-based genomic surveillance [26]. The integration of molecular diagnostics with histopathology and serology forms a comprehensive diagnostic framework, ensuring that MSDV is not only detected but also accurately characterized and differentiated from its viral mimics.
Genetic Resistance and Immunological Responses to MSDV Infection
The investigation into genetic resistance and immunological responses to Marble Spleen Disease Virus (MSDV) represents a critical frontier in understanding host-pathogen dynamics within the Siadenovirus genus of the family Adenoviridae. MSDV, identified as the etiological agent of marble spleen disease primarily in ring-necked pheasants (Phasianus colchicus) and, experimentally, in turkeys (Meleagris gallopavo), induces a characteristic splenomegaly marked by lymphoreticular hyperplasia and intranuclear inclusion bodies [2, 8]. The virus shares serological cross-reactivity and genetic lineage with hemorrhagic enteritis virus (HEV) of turkeys and the splenomegaly virus of chickens, all classified as Group II avian adenoviruses, yet distinct restriction endonuclease fingerprinting patterns underscore significant genetic divergence among these isolates [7]. Understanding how host genetics modulate susceptibility and how the avian immune system orchestrates a response to this pathogen is paramount for developing effective control strategies, particularly given the economic and ecological significance of game bird farming and the potential for MSDV to complicate diagnoses of other high-consequence pathogens, such as highly pathogenic avian influenza [3].
Heritable Basis of Resistance and Susceptibility in Galliforme Hosts
Seminal work by Boa-Amponsem and colleagues (1998) provides the most direct and comprehensive evidence for a genetic component governing resistance to MSDV. Using lines of White Leghorn chickens that had undergone long-term bidirectional selection for high (HH) or low (LL) antibody response to sheep red blood cells, the study demonstrated that these selection pressures had profound, unselected effects on resistance to MSDV [1]. Specifically, when chicks were inoculated with MSDV at 50 days of age and evaluated for splenic enlargement six days post-infection, a stark contrast emerged. Line LL chickens, selected for low antibody responsiveness, exhibited significantly smaller spleens relative to body weight compared to their HH counterparts. This reduced splenomegaly is interpreted as a marker of enhanced resistance, as the pathological hallmark of MSDV infection is the dramatic enlargement and mottling of the spleen due to viral replication and lymphoproliferation [1, 9].
The genetic architecture underlying this resistance was further elucidated through a full diallel cross design, which included parental lines, reciprocal F1 and F2 crosses, and backcrosses. The study revealed that resistance to MSDV is not a simple dominant or recessive trait. The F1 crosses were intermediate between the two parental lines but significantly different from both, indicating a lack of heterosis for resistance. Furthermore, differences between reciprocal F1 crosses pointed to a significant effect of sex-linkage, suggesting that genes on the sex chromosomes (Z in birds) play a role in determining the outcome of MSDV infection. This finding is particularly intriguing because it implies that the sex of the bird, mediated by Z-linked alleles, can directly influence susceptibility, a phenomenon observed in other avian viral diseases such as Marek's disease [1, 28]. The data also showed evidence of negative heterosis, where the crossbred progeny were more susceptible (i.e., had larger spleens) than the average of the two pure lines, a counterintuitive finding that underscores the complexity of polygenic resistance. The HH line, with its genetically programmed high antibody responsiveness, was paradoxically more susceptible to MSDV-induced splenomegaly than the LL line [1]. This suggests that the very trait selected for, high antibody production, may be detrimental in the context of MSDV, potentially diverting resources or promoting an immunopathological response that exacerbates splenic pathology rather than controlling viral replication. This intricate relationship between humoral immune capacity and disease resistance highlights that genetic selection for one aspect of immunity does not guarantee broad-spectrum protection and may, in fact, have trade-offs.
Cellular and Molecular Immunological Mechanisms in the Spleen
The spleen is the primary target organ for MSDV, and the host's immunological response within this lymphoid organ is central to the pathogenesis and outcome of infection. The virus was first demonstrated by Iltis et al. (1977) to replicate within splenic lymphoreticular cells, leading to the formation of intranuclear inclusion bodies and detection of viral antigens via direct fluorescent antibody staining [2]. The subsequent immune response is a complex interplay of innate and adaptive mechanisms aimed at controlling viral spread and eliminating infected cells, but this response can also contribute to the observed pathology.
Early innate responses likely involve the detection of viral pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs) within splenic macrophages and dendritic cells. While specific studies on MSDV are limited, parallel research on other splenotropic avian viruses, such as very virulent infectious bursal disease virus (vvIBDV) and Newcastle disease virus (NDV), provides a relevant framework. In vvIBDV infection, macrophages are rapidly activated in the spleen, leading to a surge in pro-inflammatory cytokines (e.g., IL-1β, IL-6) and chemokines as early as 2 days post-infection [13]. It is highly plausible that MSDV triggers a similar cascade, as the infiltration of macrophages and T lymphocytes is a hallmark of the splenic response to viral insult. This cytokine storm, while attempting to limit viral replication, can also cause collateral damage to the splenic architecture, contributing to the diffuse follicular necrosis and congestion observed histologically in MSDV-infected pheasants [9, 25].
Adaptive immunity, particularly the T-cell compartment, is likely critical for long-term control and clearance of MSDV. The observation of sex-linkage in resistance [1] points to the potential involvement of Z-linked immune genes, which are known to influence T-cell responses. In the context of Marek’s disease virus (MDV), another lymphotropic avian virus, the expansion of CD8+ T cells and γδ T cells is a correlate of vaccine-induced protection [29]. γδ T cells serve as a bridge between innate and adaptive immunity, and their activation could be crucial for controlling the early dissemination of MSDV. Conversely, the counterintuitive susceptibility of the HH line [1], which is hyper-responsive in antibody production, suggests that a skewed Th2-type humoral response may be ineffective or even detrimental against an intracellular pathogen like MSDV. An over-exuberant antibody response may come at the expense of a robust, protective cytotoxic T lymphocyte (CTL) response, which is typically required to eliminate virus-infected cells. This is supported by studies of NDV in chickens, where resistance is associated with a more balanced, regulated interferon-stimulated gene (ISG) response and efficient antigen presentation pathways, rather than just high antibody titers [11, 18]. The reduced expression of MHC Class II pathway genes observed in MDV-infected spleens [18] further suggests that viruses can actively subvert the host's ability to present antigens and mount an effective CD4+ T-cell response, a mechanism that MSDV may similarly exploit.
Correlates of Protection and Host-Pathogen Coevolution
Defining the immunological correlates of protection against MSDV is essential for vaccine development and for understanding natural resistance. The early research by Iltis and Jakowski (1975) demonstrated that experimentally infected birds develop antibodies detectable by agar gel immunodiffusion, which cross-reacted with HEV antigens [8]. This indicates that a humoral response is mounted, but the protective efficacy of these antibodies remains unclear. The genetic resistance conferred in the LL line [1] suggests that a lower, more regulated antibody response may be more beneficial, perhaps because it is accompanied by a more robust cell-mediated immunity.
The role of the eukaryotic translation initiation factor 2 (eIF2) family, highlighted in studies of NDV resistance [21], presents another compelling avenue for investigation. The eIF2 pathway is a key node in the cellular stress response and a direct target of viral strategies to hijack the host’s protein synthesis machinery. Differential expression of eIF2-related genes in the spleen could determine the efficiency with which MSDV can replicate, with resistant hosts possessing a more stringent translational shut-off mechanism. The upregulation of interferon-stimulated genes like IFIT5, which is highly expressed in the spleen and acts as an enhancer of innate immunity [20], would also be a predicted component of a successful antiviral response to MSDV. IFIT5 is known to be upregulated by viral RNA and can promote IRF7 and NF-κB-mediated signaling, creating a positive feedback loop that amplifies the type I interferon response [20].
From an epidemiological perspective, the existence of genetically resistant subpopulations within a species implies selective pressure imposed by MSDV over evolutionary time. The fact that MSDV, HEV, and the chicken splenomegaly virus are antigenically similar but genetically distinct [7] suggests a long history of coevolution within different galliforme hosts. The ability of a host population to evolve resistance is a dynamic process, and the widespread use of vaccination against related adenoviruses could alter this landscape. The World Organisation for Animal Health (WOAH) recognizes the importance of understanding host genetics and immune responses in managing viral diseases of poultry, as it informs both vaccination strategies and the selection of breeding stock for enhanced resistance. The Food and Agriculture Organization (FAO) also highlights that genetic resistance is a sustainable component of integrated disease management, reducing reliance on antimicrobials and chemotherapeutics. Therefore, continued research into the specific MHC haplotypes, cytokine polymorphisms, and signaling pathway dysregulations that govern the response to MSDV is not merely an academic exercise; it is a foundational element for improving the health and welfare of game birds and poultry in the face of ongoing viral threats.
References
[1] Boa-Amponsem K, Larsen C, Dunnington E, Price S, Yang A, Siegel PB. Mode of inheritance of unselected traits in lines of chickens selected for high or low antibody response to sheep red blood cells. 1. Resistance to marble spleen disease virus and juvenile body weight.. Poultry Science. 1998. DOI: https://doi.org/10.1093/PS/77.8.1073
[2] Jp I, Sb D, Ds W. Demonstration of an avian adenovirus as the causative agent of marble spleen disease.. American Journal of Veterinary Research. 1977. DOI: https://doi.org/10.2460/ajvr.1977.38.01.95
[3] Niel KR, Charles KMS, Elissa JY, Lighty ME, Ssematimba A, Culhane MR, et al.. Highly Pathogenic Avian Influenza (HPAI H5N1, Clade 2.3.4.4b, genotype C2.1) in Commercial Ring-Necked Pheasants During the 2022 Outbreak in the United States.. Canadian Journal of Microbiology (print). 2025. DOI: https://doi.org/10.1139/cjm-2025-0198
[4] Cassmann E, Zaffarano BA, Chen Q, Li G, Haynes J. Novel siadenovirus infection in a cockatiel with chronic liver disease.. Virus Research. 2019. DOI: https://doi.org/10.1016/j.virusres.2019.01.018
[5] El-Ghany WAA. A Comprehensive Review on Adenoviruses Infections in Fowl: Epidemiology, Forms, Diagnosis, and Control. . 2021. DOI: https://doi.org/10.36380/jwpr.2021.19
[6] Panigrahid S, Swain K, Routray A, Rath A, Sahoo S, Ganguly S. Inclusion Body Hepatitis and Hydropericardium Syndrome in Poultry: A Brief Review. Animal and Veterinary Sciences. 2016. DOI: https://doi.org/10.20431/2455-2518.0204002
[7] Zhang C, Nagaraja KV. Differentiation of avian adenovirus type-II strains by restriction endonuclease fingerprinting.. American Journal of Veterinary Research. 1989. DOI: https://doi.org/10.2460/ajvr.1989.50.09.1466
[8] Iltis J, Jakowski R, Wyand D. Transmission of marble spleen disease in turkeys and pheasants.. American Journal of Veterinary Research. 1975. DOI: https://doi.org/10.2460/ajvr.1975.36.01.97
[9] Lee J, Choi JH, Lee DW, Kim SJ, Fitzgerald S, Lee YS, et al.. Marble spleen disease in pheasants in Korea.. Journal of Veterinary Medical Science. 2001. DOI: https://doi.org/10.1292/JVMS.63.699
[10] Rabiei M, Low W, Ren Y, Cahyono M, Doan P, Dharmayanti I, et al.. Indicators of the molecular pathogenesis of virulent Newcastle disease virus in chickens revealed by transcriptomic profiling of spleen. Scientific Reports. 2020. DOI: https://doi.org/10.1038/s41598-021-96929-w
[11] Zhang J, Kaiser M, Deist MS, Gallardo R, Bunn D, Kelly T, et al.. Transcriptome Analysis in Spleen Reveals Differential Regulation of Response to Newcastle Disease Virus in Two Chicken Lines. Scientific Reports. 2018. DOI: https://doi.org/10.1038/s41598-018-19754-8
[12] Hu Z, Gu H, Hu J, Hu S, Wang X, Liu X, et al.. Quantitative proteomics identify an association between extracellular matrix degradation and immunopathology of genotype VII Newcastle disease virus in the spleen in chickens.. Journal of Proteomics. 2018. DOI: https://doi.org/10.1016/j.jprot.2018.04.019
[13] Rasoli M, Yeap S, Tan SW, Roohani K, Kristeen-Teo YW, Alitheen N, et al.. Differential modulation of immune response and cytokine profiles in the bursae and spleen of chickens infected with very virulent infectious bursal disease virus. BMC Veterinary Research. 2015. DOI: https://doi.org/10.1186/s12917-015-0377-x
[14] Kai Y, Hu Z, Xu H, Hu S, Zhu J, Hu J, et al.. The M, F and HN genes of genotype VIId Newcastle disease virus are associated with the severe pathological changes in the spleen of chickens. Virology Journal. 2015. DOI: https://doi.org/10.1186/s12985-015-0366-5
[15] Lian L, Qu L, Sun H, Chen Y, Lamont S, Liu C, et al.. Gene expression analysis of host spleen responses to Marek's disease virus infection at late tumor transformation phase.. Poultry Science. 2012. DOI: https://doi.org/10.3382/ps.2012-02226
[16] Fan L, Wang Y, Jiang N, Chen M, Gao L, Li K, et al.. Novel variant infectious bursal disease virus suppresses Newcastle disease vaccination in broiler and layer chickens. Poultry Science. 2020. DOI: https://doi.org/10.1016/j.psj.2020.09.037
[17] Lee L, Sharma JM, Nazerian K, Witter R. Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus.. Journal of Immunology. 1978. DOI: https://doi.org/10.4049/jimmunol.120.5.1554
[18] Lian L, Qu L, Zheng J, Liu C, Zhang Y, Chen Y, et al.. Expression profiles of genes within a subregion of chicken major histocompatibility complex B in spleen after Marek's disease virus infection.. Poultry Science. 2010. DOI: https://doi.org/10.3382/ps.2010-00919
[19] Thanthrige-Don N, Abdul-Careem MF, Shack L, Burgess SC, Sharif S. Analyses of the spleen proteome of chickens infected with Marek's disease virus. Virology. 2009. DOI: https://doi.org/10.1016/j.virol.2009.05.020
[20] Li J, Yin Y, Yang H, Yang C, Yu C, Wang Y, et al.. mRNA expression and functional analysis of chicken IFIT5 after infected with Newcastle disease virus.. Infection, Genetics and Evolution. 2020. DOI: https://doi.org/10.1016/j.meegid.2020.104585
[21] Vesco APD, Kaiser M, Monson MS, Zhou H, Lamont S. Genetic responses of inbred chicken lines illustrate importance of eIF2 family and immune-related genes in resistance to Newcastle disease virus. Scientific Reports. 2020. DOI: https://doi.org/10.1038/s41598-020-63074-9
[22] Henry C, Brewer RN, Edgar SA, Gray BW. Studies on infectious bursal disease in chickens. 2. Scoring microscopic lesions in the bursa of fabricius, thymus, spleen, and kidney in gnotobiotic and battery reared White Leghorns experimentally infected with infectious bursal disease virus.. Poultry Science. 1980. DOI: https://doi.org/10.3382/PS.0591006
[23] Adcock KG, Berghaus RD, Goodwin CC, Ruder M, Yabsley MJ, Mead DG, et al.. LYMPHOPROLIFERATIVE DISEASE VIRUS AND RETICULOENDOTHELIOSIS VIRUS DETECTION AND DISEASE IN WILD TURKEYS (MELEAGRIS GALLOPAVO). Journal of Wildlife Diseases. 2023. DOI: https://doi.org/10.7589/JWD-D-23-00012
[24] Lian J, Wang Z, Xu Z, Pang Y, Leng M, Tang S, et al.. Pathogenicity and molecular characterization of infectious bursal disease virus in China. Poultry Science. 2021. DOI: https://doi.org/10.1016/j.psj.2021.101502
[25] Elfatah KSA, Elabasy M, El-khyate F, Elmahallawy E, Mosad SM, El-Gohary F, et al.. Molecular Characterization of Velogenic Newcastle Disease Virus (Sub-Genotype VII.1.1) from Wild Birds, with Assessment of Its Pathogenicity in Susceptible Chickens. Animals. 2021. DOI: https://doi.org/10.3390/ani11020505
[26] Alathari S, Chaput DL, Bolaños LM, Joseph A, Jackson VL, Verner-Jeffreys D, et al.. A Multiplexed, Tiled PCR Method for Rapid Whole-Genome Sequencing of Infectious Spleen and Kidney Necrosis Virus (ISKNV) in Tilapia. Viruses. 2023. DOI: https://doi.org/10.3390/v15040965
[27] Shi M, Li M, Wang P, Wang W, Li H, Gao Y, et al.. An outbreak in three-yellow chickens with clinical tumors of high mortality caused by the coinfection of reticuloendotheliosis virus and Marek’s disease virus: a speculated reticuloendotheliosis virus contamination plays an important role in the case. Poultry Science. 2020. DOI: https://doi.org/10.1016/j.psj.2020.09.034
[28] Jin H, Kong Z, Mehboob A, Jiang B, Xu J, Cai Y, et al.. Transcriptional Profiles Associated with Marek’s Disease Virus in Bursa and Spleen Lymphocytes Reveal Contrasting Immune Responses during Early Cytolytic Infection. Viruses. 2020. DOI: https://doi.org/10.3390/v12030354
[29] Hao X, Li S, Li J, Yang Y, Qin A, Shang S. An Anti-Tumor Vaccine Against Marek's Disease Virus Induces Differential Activation and Memory Response of γδ T Cells and CD8 T Cells in Chickens. Frontiers in Immunology. 2021. DOI: https://doi.org/10.3389/fimmu.2021.645426